Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

75 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Added Value of Reanalysis of Whole Exome- and Whole Genome Sequencing Data From Patients Suspected of Primary Immune Deficiency Using an Extended Gene Panel and Structural Variation Calling.
Mørup SB, Nazaryan-Petersen L, Gabrielaite M, Reekie J, Marquart HV, Hartling HJ, Marvig RL, Katzenstein TL, Masmas TN, Lundgren J, Murray DD, Helleberg M, Borgwardt L. Mørup SB, et al. Among authors: marquart hv. Front Immunol. 2022 Jun 30;13:906328. doi: 10.3389/fimmu.2022.906328. eCollection 2022. Front Immunol. 2022. PMID: 35874679 Free PMC article. Review.
Improved Overall Survival, Relapse-Free-Survival, and Less Graft-vs.-Host-Disease in Patients With High Immune Reconstitution of TCR Gamma Delta Cells 2 Months After Allogeneic Stem Cell Transplantation.
Minculescu L, Marquart HV, Ryder LP, Andersen NS, Schjoedt I, Friis LS, Kornblit BT, Petersen SL, Haastrup E, Fischer-Nielsen A, Reekie J, Sengelov H. Minculescu L, et al. Among authors: marquart hv. Front Immunol. 2019 Aug 22;10:1997. doi: 10.3389/fimmu.2019.01997. eCollection 2019. Front Immunol. 2019. PMID: 31507601 Free PMC article.
Improved Relapse-Free Survival in Patients With High Natural Killer Cell Doses in Grafts and During Early Immune Reconstitution After Allogeneic Stem Cell Transplantation.
Minculescu L, Fischer-Nielsen A, Haastrup E, Ryder LP, Andersen NS, Schjoedt I, Friis LS, Kornblit BT, Petersen SL, Sengelov H, Marquart HV. Minculescu L, et al. Among authors: marquart hv. Front Immunol. 2020 May 29;11:1068. doi: 10.3389/fimmu.2020.01068. eCollection 2020. Front Immunol. 2020. PMID: 32547559 Free PMC article.
Granulocyte Colony-Stimulating Factor Effectively Mobilizes TCR γδ and NK Cells Providing an Allograft Potentially Enhanced for the Graft-Versus-Leukemia Effect for Allogeneic Stem Cell Transplantation.
Minculescu L, Sengelov H, Marquart HV, Ryder LP, Fischer-Nielsen A, Haastrup E. Minculescu L, et al. Among authors: marquart hv. Front Immunol. 2021 Mar 10;12:625165. doi: 10.3389/fimmu.2021.625165. eCollection 2021. Front Immunol. 2021. PMID: 33777007 Free PMC article.
Fatal JC-virus Granular Cerebellar Neuronopathy in a Patient Diagnosed with ALPS and Hypogammaglobulinemia.
Helweg-Larsen J, Rasmussen M, Marquart HV, Kondziella D; PIDVIR Consortium; Marvig RL, Rosenstierne MW, Bay JT, Ryder LP, Gjerdrum LMR, Bangsgaard R, Gideon P, Sellebjerg FT, Fomsgaard A. Helweg-Larsen J, et al. Among authors: marquart hv. J Clin Immunol. 2022 May;42(4):869-872. doi: 10.1007/s10875-022-01227-3. Epub 2022 Feb 17. J Clin Immunol. 2022. PMID: 35178641 No abstract available.
Life-threatening viral disease in a novel form of autosomal recessive IFNAR2 deficiency in the Arctic.
Duncan CJA, Skouboe MK, Howarth S, Hollensen AK, Chen R, Børresen ML, Thompson BJ, Stremenova Spegarova J, Hatton CF, Stæger FF, Andersen MK, Whittaker J, Paludan SR, Jørgensen SE, Thomsen MK, Mikkelsen JG, Heilmann C, Buhas D, Øbro NF, Bay JT, Marquart HV, de la Morena MT, Klejka JA, Hirschfeld M, Borgwardt L, Forss I, Masmas T, Poulsen A, Noya F, Rouleau G, Hansen T, Zhou S, Albrechtsen A, Alizadehfar R, Allenspach EJ, Hambleton S, Mogensen TH. Duncan CJA, et al. Among authors: marquart hv. J Exp Med. 2022 Jun 6;219(6):e20212427. doi: 10.1084/jem.20212427. Epub 2022 Apr 20. J Exp Med. 2022. PMID: 35442417 Free PMC article.
Early stimulated immune responses predict clinical disease severity in hospitalized COVID-19 patients.
Svanberg R, MacPherson C, Zucco A, Agius R, Faitova T, Andersen MA, da Cunha-Bang C, Gjærde LK, Møller MEE, Brooks PT, Lindegaard B, Sejdic A, Gang AO, Hersby DS, Brieghel C, Nielsen SD, Podlekareva D, Hald A, Bay JT, Marquart H, Lundgren J, Lebech AM, Helleberg M, Niemann CU, Ostrowski SR. Svanberg R, et al. Commun Med (Lond). 2022 Sep 12;2:114. doi: 10.1038/s43856-022-00178-5. eCollection 2022. Commun Med (Lond). 2022. PMID: 36101705 Free PMC article.
Improved Innate Immune Function in Patients with Chronic Lymphocytic Leukemia Treated with Targeted Therapy in Clinical Trials.
Svanberg Teglgaard R, Marquart HV, Hartling HJ, Bay JT, da Cunha-Bang C, Brieghel C, Faitová T, Enggaard L, Kater AP, Levin MD, Kersting S, Ostrowski SR, Niemann CU. Svanberg Teglgaard R, et al. Among authors: marquart hv. Clin Cancer Res. 2024 May 1;30(9):1959-1971. doi: 10.1158/1078-0432.CCR-23-2522. Clin Cancer Res. 2024. PMID: 38393694
75 results